Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Thomas

Showing results (191-200 of 217) with videos related to

Pageof 22
Sort By:
Cold Spring Harbor Molecular Case Studies|April 3, 2019
Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastasesMark J McCabe, Mark Pinese, Chia-Ling Chan, et al.
JAMA Oncology|November 13, 2025
Nivolumab and Ipilimumab in Advanced Mismatch Repair-Deficient/Microsatellite Instability-High Noncolorectal Cancers: A Nonrandomized Clinical TrialMatteo S Carlino, Bo Gao, Michael Michael, et al.
Lancet (London, England)|June 24, 2019
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trialWilliam D Tap, Hans Gelderblom, Emanuela Palmerini, et al.
Science (New York, N.Y.)|June 6, 2020
MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancerArcadi Cipponi, David L Goode, Justin Bedo, et al.
Molecular Systems Biology|October 1, 2025
High-throughput 3D engineered paediatric tumour models for precision medicineMoonSun Jung, Valentina Poltavets, Joanna N Skhinas, et al.
Cancer Research|June 22, 2017
Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma SubtypesEmmy D G Fleuren, Myrella Vlenterie, Winette T A van der Graaf, et al.
The Lancet. Oncology|August 9, 2016
Monogenic and polygenic determinants of sarcoma risk: an international genetic studyMandy L Ballinger, David L Goode, Isabelle Ray-Coquard, et al.
Cancer Epidemiology|August 18, 2023
Genetically inferred birthweight, height, and puberty timing and risk of osteosarcomaD Matthew Gianferante, Amy Moore, Logan G Spector, et al.
JAMA Oncology|March 5, 2026
Genomic Therapy Matching in Rare and Refractory CancersFrank P Lin, Subotheni Thavaneswaran, John P Grady, et al.
International Journal of Cancer|December 7, 2017
Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patientsRoelof Koster, Orestis A Panagiotou, William A Wheeler, et al.
Pageof 22

Showing results (191-200 of 217) with videos related to

Sort By:
Pageof 22
Cold Spring Harbor Molecular Case Studies|April 3, 2019
Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastasesMark J McCabe, Mark Pinese, Chia-Ling Chan, et al.
JAMA Oncology|November 13, 2025
Nivolumab and Ipilimumab in Advanced Mismatch Repair-Deficient/Microsatellite Instability-High Noncolorectal Cancers: A Nonrandomized Clinical TrialMatteo S Carlino, Bo Gao, Michael Michael, et al.
Lancet (London, England)|June 24, 2019
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trialWilliam D Tap, Hans Gelderblom, Emanuela Palmerini, et al.
Science (New York, N.Y.)|June 6, 2020
MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancerArcadi Cipponi, David L Goode, Justin Bedo, et al.
Molecular Systems Biology|October 1, 2025
High-throughput 3D engineered paediatric tumour models for precision medicineMoonSun Jung, Valentina Poltavets, Joanna N Skhinas, et al.
Cancer Research|June 22, 2017
Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma SubtypesEmmy D G Fleuren, Myrella Vlenterie, Winette T A van der Graaf, et al.
The Lancet. Oncology|August 9, 2016
Monogenic and polygenic determinants of sarcoma risk: an international genetic studyMandy L Ballinger, David L Goode, Isabelle Ray-Coquard, et al.
Cancer Epidemiology|August 18, 2023
Genetically inferred birthweight, height, and puberty timing and risk of osteosarcomaD Matthew Gianferante, Amy Moore, Logan G Spector, et al.
JAMA Oncology|March 5, 2026
Genomic Therapy Matching in Rare and Refractory CancersFrank P Lin, Subotheni Thavaneswaran, John P Grady, et al.
International Journal of Cancer|December 7, 2017
Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patientsRoelof Koster, Orestis A Panagiotou, William A Wheeler, et al.
Pageof 22